Sorafenib in Myelodysplastic Syndrome

Clinical trial NCT00510289 · TERMINATED

Trial details

NCT number: NCT00510289
Sponsor: Duke University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Leukemia, Myelomonocytic, Chronic

Start date: 2006-07-01
Primary completion: 2011-07-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.